Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biologicals ; 67: 81-87, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32739117

ABSTRACT

The muscle-relaxing effects of the botulinum neurotoxin (BoNT) serotypes A and B are widely used in clinical and aesthetic medicine. The standard method for measuring the biological activity of pharmaceutical BoNT products is a mouse bioassay. In line with the European Directive 2010/63/EU, a replacement by an animal-free method would be desirable. Whereas the existing approved in vitro methods for BoNT activity measurements are product-specific and not freely available for all users, the "binding and cleavage" (BINACLE) assay could become a widely applicable alternative. This method quantifies active BoNT molecules based on their specific receptor-binding and proteolytic properties and can be applied to all BoNT products on the European market. Here we describe the results of a transferability study, in which identical BoNT samples were tested in the BINACLE assay in four laboratories. All participants successfully performed the method and observed clear dose-response relationships. Assay variability was within an acceptable range. These data indicate that the BoNT BINACLE assay is robust and can be straightforwardly transferred between laboratories. They thus provide an appropriate basis for future studies to further substantiate the suitability of the BINACLE assay for the potency determination of BoNT products.


Subject(s)
Biological Assay/methods , Botulinum Toxins/analysis , Botulinum Toxins/metabolism , Clinical Laboratory Techniques/methods , Animals , Biological Assay/trends , Humans , Mice , Protein Binding , Proteolysis , Reproducibility of Results
2.
J Control Release ; 158(3): 424-32, 2012 Mar 28.
Article in English | MEDLINE | ID: mdl-22197778

ABSTRACT

Cell and gene therapies have an enormous range of potential applications, but as for most other therapies, dosing is a critical issue, which makes regulated gene expression a prerequisite for advanced strategies. Several inducible expression systems have been established, which mainly rely on small molecules as inducers, such as hormones or antibiotics. The application of these inducers is difficult to control and the effects on gene regulation are slow. Here we describe a novel system for induction of gene expression in encapsulated cells. This involves the modification of cells to express potential therapeutic genes under the control of a heat inducible promoter and the co-encapsulation of these cells with magnetic nanoparticles. These nanoparticles produce heat when subjected to an alternating magnetic field; the elevated temperatures in the capsules then induce gene expression. In the present study we define the parameters of such systems and provide proof-of-principle using reporter gene constructs. The fine-tuned heating of nanoparticles in the magnetic field allows regulation of gene expression from the outside over a broad range and within short time. Such a system has great potential for advancement of cell and gene therapy approaches.


Subject(s)
Ferric Compounds/administration & dosage , Gene Expression Regulation , Magnetic Fields , Metal Nanoparticles/administration & dosage , Genes, Reporter/genetics , Green Fluorescent Proteins/genetics , HEK293 Cells , Heat-Shock Proteins/genetics , Humans , Hyperthermia, Induced , Luciferases/genetics , Polymers/chemistry , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism
3.
Eur J Biochem ; 269(18): 4458-67, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12230557

ABSTRACT

The envelope protein gp64 of the baculovirus Autographa californica nuclear polyhedrosis virus is essential for viral entry into insect cells, as the glycoprotein both mediates pH-dependent membrane fusion and binds to host cell receptors. Surface modification of baculovirus particles by genetic engineering of gp64 has been demonstrated by various strategies and thus has become an important and powerful tool in molecular biology. To improve further the presentation of peptides on the surface of baculovirus particles, several insertion sites within the gp64 envelope protein were selected by their theoretical maximum surface probability and investigated for efficient peptide presentation. The ELDKWA peptide of the gp41 of HIV-1, specific for the human mAb 2F5, was inserted into 17 different positions of the glycoprotein gp64. Propagation of viruses was successful in 13 cases, mutagenesis at four positions did not result in production of intact virus particles. Western blotting, FACS analysis and ELISA were used for characterization of the different binding properties of the mutants. Insertion of this peptide into the native envelope protein resulted in high avidity display on the surface of baculovirus particles. This approach offers the possibility of effective modification of surface properties in regard to host range specificity and antigen display.


Subject(s)
Baculoviridae/physiology , Viral Fusion Proteins/physiology , Amino Acid Sequence , Baculoviridae/genetics , Epitopes , HIV Envelope Protein gp41/genetics , HIV Envelope Protein gp41/immunology , HIV Envelope Protein gp41/physiology , Humans , Molecular Sequence Data , Mutagenesis, Insertional , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Surface Properties , Viral Fusion Proteins/genetics , Viral Fusion Proteins/immunology , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...